Loss of proteostasis is one of the twelve recognized hallmarks of biological aging and the primary mechanism by which the skin’s cellular quality-control network fails over time. When the systems responsible for protein synthesis, folding, and clearance lose efficiency, misfolded proteins accumulate, bioenergetic reserves collapse, and the structural architecture of the dermis enters a state of progressive, self-reinforcing decay.
Content
What is proteostasis? Defining the cellular quality-control network
Proteostasis, by definition, protein homeostasis; is the intricate cellular quality-control network responsible for maintaining the functional integrity of the proteome. It regulates the continuous synthesis, precise conformational folding, trafficking, and selective degradation of proteins within the cell. In skin biology, this network prevents the accumulation of toxic protein aggregates and ensures cellular healthspan.
The skin proteome experiences constant exposure to intrinsic metabolic byproducts and extrinsic environmental stressors. Proteostasis acts as a biological buffer, coordinating molecular machinery to repair damaged structural elements and clear non-functional metabolic waste. As skin ages, the efficiency of this system wanes, marking a critical transition from healthy tissue regeneration to cellular decay.
Cellular proteostasis in skin: Keratinocytes and dermal fibroblasts
Skin tissue longevity relies on specialized proteostatic machinery within distinct cellular compartments: epidermal keratinocytes and dermal fibroblasts. Keratinocytes demand high proteasomal throughput to support rapid turnover and cornification, while long-lived dermal fibroblasts depend on lysosomal pathways to maintain ECM synthesis.
In the epidermis, keratinocytes process large volumes of structural proteins like cytokeratins and filaggrin. The Ubiquitin-Proteasome System (UPS) clears oxidative intermediate proteins to maintain effective epidermal differentiation and barrier function.
Conversely, dermal fibroblasts are slow-dividing, long-lived cells responsible for producing structural proteins including type I collagen, type III collagen, and elastin. Because fibroblasts must maintain proteome integrity over decades, they rely heavily on chaperone-mediated autophagy and macroautophagy. A decline in fibroblast proteostasis compromises extracellular matrix integrity, leading to dermal thinning, loss of elasticity, and reduced structural firmness.
Loss of proteostasis: a primary hallmark of aging
The loss of proteostasis is an upstream hallmark of biological aging that directly destabilizes skin tissue architecture. When protein quality-control systems fail, damaged molecules accumulate, causing cellular stress, bioenergetic depletion, and secondary hallmarks such as cellular senescence.
┌──────────────────────────────────────────┐
│ ENVIRONMENTAL & METABOLIC STRESS
│ (UV Radiation, ROS, Pollution, Glycation)
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ LOSS OF PROTEOSTASIS
│ • Chaperone Exhaustion • Proteasomal Inhibition
│ • Impaired Autophagy • Misfolded Protein Aggregation
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ SECONDARY CELLULAR CONSEQUENCES
│ • Bioenergetic Decline (Mitochondrial Exhaustion / ATP Loss)
│ • Induction of Senescence & SASP Secretion (IL-6, IL-8, MMPs)
│ • Structural Collapse of Extracellular Matrix (ECM)
└──────────────────────────────────────────┘
Proteostatic maintenance is an energy-intensive process requiring high consumption of cellular adenosine triphosphate (ATP). As dermal and epidermal cells experience age-related mitochondrial dysfunction, the resulting ATP deficit starves energy-dependent proteasomes and chaperone networks.
This energy crisis triggers a self-reinforcing cycle of cellular damage: uncleared misfolded proteins clog proteasomal active sites, which increases intracellular stress, further damages mitochondria, and accelerates skin degradation.
Pillar one: protein folding and protein misfolding causes
Hydrophobic amino acid residues are typically buried within a protein’s internal core during folding. Reactive Oxygen Species (ROS), ultraviolet (UV) radiation, and thermal stress disrupt these weak non-covalent interactions, exposing hydrophobic regions. These exposed segments bond non-specifically with neighboring damaged polypeptides, forming insoluble misfolded structures.
In aging skin, this aggregation process is chronically accelerated by declining antioxidant enzyme reserves, creating a persistent backlog of misfolded proteins that exceeds the clearance capacity of both the UPS and lysosomal pathways, and directly initiating the loss of proteostasis cycle.
Pillar two: quality control and loss of proteostasis aging
The two primary clearance systems in skin cells are the Ubiquitin-Proteasome System (UPS) and the Lysosomal-Autophagic System. The UPS tags soluble, short-lived proteins with ubiquitin molecules for degradation within the 20S/26S proteasome complex.
Larger aggregates, lipid droplets, and damaged mitochondria (mitophagy) require lysosomal degradation. Aging reduces the expression of critical autophagy-related genes (including ATG5, ATG7, and BECN1) and degrades lysosomal membrane receptors like LAMP2A, impairing cellular waste management.
Pillar three: stress response and what is loss of proteostasis in practice
Cells deploy specialized molecular chaperones, predominantly Heat Shock Proteins (HSPs such as HSP70 and HSP90), to shield exposed hydrophobic regions during environmental stress. In practice, age-related chaperone degradation leads to unassisted protein aggregation.
When misfolded proteins escape both chaperone refolding and autophagic clearance, they form high-molecular-weight cross-linked aggregates that disrupt intracellular transport and induce cellular stress.
Causes and biomarkers of loss of proteostasis in aging skin
Misfolded protein diseases and their cutaneous consequences
Systemic misfolded protein conditions offer critical insights into cutaneous aging mechanisms. In aging skin, uncleared protein aggregates and Advanced Glycation End-products (AGEs) cross-link structural proteins, reducing biomechanical compliance and skin elasticity.
Advanced glycation occurs when reducing sugars react non-enzymatically with long-lived collagen and elastin fibers. This process forms intermolecular cross-links that stiffen the extracellular matrix and alter cell-matrix signaling via Integrin receptors.
Fibroblasts cultured on glycated, stiffened matrices show reduced cell spreading, diminished proliferative capacity, and elevated expression of matrix metalloproteinases (MMPs), converting local structural tissue into a degraded matrix environment.
Cellular accumulation: the hallmark that turns damaged proteins into decay
Persistent intracellular protein aggregation triggers the DNA damage response and induces cellular senescence. Senescent cells permanently exit the cell cycle and secrete the Senescence-Associated Secretory Phenotype (SASP), spreading localized inflammation across neighboring healthy skin tissue.
┌──────────────────────────────────────────┐
│ UNCLEARED PROTEIN AGGREGATES
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ PERSISTENT DNA DAMAGE RESPONSE (DDR)
│ (p16INK4a & p21CIP1 Activation)
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ SENESCENT CELL ARREST
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ SASP SECRETION PROFILE RELEASE
│ • Pro-inflammatory Cytokines: IL-1β, IL-6, IL-8
│ • Matrix Metalloproteinases: MMP-1, MMP-3, MMP-9
└──────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────┐
│ ECM PARACRINE DEGRADATION
│ • Cleavage of Type I Collagen and Elastin Fibers
│ • Spread of Senescence to Neighboring Healthy Fibroblasts
└──────────────────────────────────────────┘
The accumulation of protein aggregates acts as a persistent stress signal, upregulating cell cycle inhibitors including p16INK4a and p21CIP1. Once senescent, fibroblasts convert from structural collagen producers into pro-inflammatory secretors.
The SASP secretion profile includes cytokines (IL-1$\beta$, IL-6, IL-8) and enzymes (MMP-1, MMP-3, MMP-9) that degrade intact dermal collagen and elastin fibers. This paracrine signaling damages neighboring healthy cells, accelerating dermal tissue breakdown.
Lifestyle and longevity: daily habits that protect cellular proteostasis
Targeted lifestyle habits help protect skin proteostasis by modulating nutrient-sensing pathways. Caloric restriction, intermittent thermal stress, and circadian alignment regulate key metabolic controllers, including mTORC1 and AMPK, to stimulate internal autophagic clearing.
- Caloric restriction mimetics: Downregulating the nutrient sensor mTORC1 while activating AMP-activated protein kinase (AMPK) stimulates autophagy, clearing intracellular debris before aggregates form.
- Circadian alignment: Autophagic clearance peaks during sleep, guided by core clock genes (CLOCK, BMAL1). Disrupted circadian rhythms reduce nighttime proteasomal degradation, increasing daytime susceptibility to UV-induced oxidative stress.
- Thermal stress (Hormesis): Mild, transient heat exposure induces Heat Shock Factor 1 (HSF1), upregulating protective molecular chaperones like HSP70.
Provital and the science of proteostasis: a research-driven approach
Provital develops cosmetic active ingredients through sustainable plant biotechnology and cellular longevity research. By leveraging plant stem cell cultures, upcycled botanical byproducts, and high-precision bio-ferments, Provital targets core mechanisms of cellular aging.
Applying advanced 3D reconstructed human skin models and bioinformatic analytical tools allows precise evaluation of active ingredients on cell degradation and clearing pathways. This science-driven approach provides beauty brands with validated bio-longevity ingredients that help restore proteome integrity.
Provital – mechanism of action for proteostasis restoration
Proteasomal degradation and chaperone-assisted refolding depend directly on cellular ATP availability. Energen™ provides a targeted strategy to boost bioenergetic capacity, supplying the energy required to support active proteostasis.
Energen™ combines saponosides from Sapindus mukorossi within a hydrocolloid matrix derived from Caesalpinia spinosa gum (3D Matrix Technology). The matrix remains on the skin surface, sequentially releasing low-molecular-weight saponosides that penetrate to the dermis.
Energen™ has been proved to increase the amount of cellular ATP when applied to fibroblast cultures (+21.8%, in vitro) by optimizing mitochondrial electron transport. By replenishing the cell’s energy currency, Energen™ helps sustain the bioenergetic conditions that energy-intensive quality-control machinery, including the 26S proteasome and molecular chaperones, requires to operate.
In vitro and in vivo validation of Energen™
Several studies validate the efficacy of Energen™ in restoring cellular energy and improving skin structural parameters. Quantitative measurements demonstrate increased intracellular energy production alongside improvements in skin firmness and surface texture.
| Tested Parameter | Method / Model | Measured Efficacy Outcome |
| Cellular ATP production | In Vitro Fibroblast Assay (Energen™ 1%) | +21.8% increase in intracellular ATP levels |
| Skin tonification | In Vivo Cutometer Evaluation | +8.8% improvement in skin tone |
| Surface relief imperfections | In Vivo Topographic Analysis | -12% reduction in global skin relief (RT) |
| Skin hydration | In Vivo Corneometry Evaluation | +8.45% increase in skin hydration |
In the in vivo study by Provital, Energen™ demonstrated clear improvements in skin tonification and smoothness, confirming that supporting cellular energy helps maintain tissue structure and surface quality.
FAQs about proteostasis and cellular aging
Can loss of proteostasis be reversed? Current scientific evidence
While chronological age cannot be halted, scientific research shows that latent proteostatic mechanisms can be reactivated. Topical biotechs that stimulate autophagic recycling pathways (via mTORC1 inhibition or AMPK activation) and boost cellular ATP levels can restore intracellular waste clearance, reduce protein aggregation, and improve skin healthspan.
What is the difference between proteostasis and cellular senescence?
Proteostasis refers to the continuous cellular quality-control network that manages protein folding, maintenance, and degradation. Cellular senescence is a terminal cell-cycle arrest state triggered when damaged proteins and DNA cannot be cleared, causing cells to secrete pro-inflammatory SASP factors that degrade the surrounding extracellular matrix.
What triggers protein misfolding besides aging?
Protein misfolding is triggered by extrinsic and intrinsic factors, including solar UV radiation, reactive oxygen species (ROS), urban particulate pollution, heat stress, and diet-derived Advanced Glycation End-products (AGEs). These stressors alter non-covalent amino acid bonds, exposing hydrophobic regions that form insoluble protein aggregates.
At what age does proteostasis decline typically begin?
Subclinical proteostatic decline begins in the late 20s to early 30s as basal mitochondrial ATP production decreases and protective enzyme levels decline. Without targeted intervention, this decline accelerates by age 40, leading to visible loss of firmness, reduced barrier resilience, and diminished skin elasticity.
For further information or insights on this topic, please do not hesitate to contact our team of experts, who are available to provide guidance and support in selecting the most suitable solutions for your requirements.
No comments yet
There are no comments on this post yet.
Leave a comment